Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

GABAB receptor allosteric modulators exhibit pathway-dependent and species-selective activity.

Sturchler E, Li X, de Lourdes Ladino M, Kaczanowska K, Cameron M, Griffin PR, Finn MG, Markou A, McDonald P.

Pharmacol Res Perspect. 2017 Mar 24;5(2):e00288. doi: 10.1002/prp2.288. eCollection 2017 Apr.

2.

A Role for the GIRK3 Subunit in Methamphetamine-Induced Attenuation of GABAB Receptor-Activated GIRK Currents in VTA Dopamine Neurons.

Munoz MB, Padgett CL, Rifkin R, Terunuma M, Wickman K, Contet C, Moss SJ, Slesinger PA.

J Neurosci. 2016 Mar 16;36(11):3106-14. doi: 10.1523/JNEUROSCI.1327-15.2016.

3.

Identifying the role of pre-and postsynaptic GABA(B) receptors in behavior.

Kasten CR, Boehm SL 2nd.

Neurosci Biobehav Rev. 2015 Oct;57:70-87. doi: 10.1016/j.neubiorev.2015.08.007. Epub 2015 Aug 15. Review.

4.

Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects.

Cohen-Barak O, Wildeman J, van de Wetering J, Hettinga J, Schuilenga-Hut P, Gross A, Clark S, Bassan M, Gilgun-Sherki Y, Mendzelevski B, Spiegelstein O.

J Clin Pharmacol. 2015 May;55(5):573-83. doi: 10.1002/jcph.450. Epub 2015 Jan 12.

5.

Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues.

Young KA, Franklin TR, Roberts DC, Jagannathan K, Suh JJ, Wetherill RR, Wang Z, Kampman KM, O'Brien CP, Childress AR.

J Neurosci. 2014 Apr 2;34(14):5038-43. doi: 10.1523/JNEUROSCI.4977-13.2014.

6.

Endocannabinoids promote cocaine-induced impulsivity and its rapid dopaminergic correlates.

Hernandez G, Oleson EB, Gentry RN, Abbas Z, Bernstein DL, Arvanitogiannis A, Cheer JF.

Biol Psychiatry. 2014 Mar 15;75(6):487-98. doi: 10.1016/j.biopsych.2013.09.005. Epub 2013 Oct 17.

7.

Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice.

Li X, Risbrough VB, Cates-Gatto C, Kaczanowska K, Finn MG, Roberts AJ, Markou A.

Neuropharmacology. 2013 Jul;70:156-67. doi: 10.1016/j.neuropharm.2013.01.018. Epub 2013 Jan 29.

8.
9.

Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats.

Maccioni P, Zaru A, Loi B, Lobina C, Carai MA, Gessa GL, Capra A, Mugnaini C, Pasquini S, Corelli F, Hyytiä P, Lumeng L, Colombo G.

Alcohol Clin Exp Res. 2012 Oct;36(10):1748-66. doi: 10.1111/j.1530-0277.2012.01782.x. Epub 2012 Apr 6.

10.

Activation of the GABA(B) Receptor Prevents Nicotine-Induced Locomotor Stimulation in Mice.

Lobina C, Carai MA, Froestl W, Mugnaini C, Pasquini S, Corelli F, Gessa GL, Colombo G.

Front Psychiatry. 2011 Dec 30;2:76. doi: 10.3389/fpsyt.2011.00076. eCollection 2011.

11.

Baclofen facilitates the extinction of methamphetamine-induced conditioned place preference in rats.

Voigt RM, Herrold AA, Napier TC.

Behav Neurosci. 2011 Apr;125(2):261-7. doi: 10.1037/a0022893.

12.

The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.

Wierońska JM, Kusek M, Tokarski K, Wabno J, Froestl W, Pilc A.

Br J Pharmacol. 2011 Jul;163(5):1034-47. doi: 10.1111/j.1476-5381.2011.01301.x.

13.

Administration of GABA(B) receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference.

Voigt RM, Herrold AA, Riddle JL, Napier TC.

Behav Brain Res. 2011 Jan 1;216(1):419-23. doi: 10.1016/j.bbr.2010.08.034. Epub 2010 Sep 8.

14.

Localization of dopamine- and cAMP-regulated phosphoprotein-32 and inhibitor-1 in area 9 of Macaca mulatta prefrontal cortex.

Glausier JR, Maddox M, Hemmings HC Jr, Nairn AC, Greengard P, Muly EC.

Neuroscience. 2010 May 5;167(2):428-38. doi: 10.1016/j.neuroscience.2010.02.014. Epub 2010 Feb 13.

15.

Allosteric modulators of GABA(B) receptors: mechanism of action and therapeutic perspective.

Pin JP, Prézeau L.

Curr Neuropharmacol. 2007 Sep;5(3):195-201. doi: 10.2174/157015907781695919.

16.

Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats.

Paterson NE, Vlachou S, Guery S, Kaupmann K, Froestl W, Markou A.

J Pharmacol Exp Ther. 2008 Jul;326(1):306-14. doi: 10.1124/jpet.108.139204. Epub 2008 Apr 29.

Supplemental Content

Support Center